ArticleJAMA health forum2024
Drug Prices After Patent Expirations in High-Income Countries and Implications for Cost-Effectiveness Analyses.
Miquel Serra-Burriel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it